Kosvo Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 68.67%
- Profit Growth -118.60%
- Ebitda -1.93%
- Net Worth -1.75%
- Total Assets 1.76%
About Kosvo Pharmaceuticals India
Kosvo Pharmaceuticals India Private Limited (KPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 September 2018 (Six years and five months 2 days old ). Its registered office is in Agra, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pritish Agarwal and Bhawana Agarwal serve as directors at the Company.
Company Details
- Location
Agra, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U93000UP2018PTC108173
- Company No.
108173
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2018
- Date of AGM
25 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Kosvo Pharmaceuticals India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pritish Agarwal  | Director | 20-Sep-2018 | Current |
| Bhawana Agarwal | Director | 20-Sep-2018 | Current |
Financial Performance of Kosvo Pharmaceuticals India.
Kosvo Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 68.67% increase. The company also saw a substantial fall in profitability, with a 118.6% decrease in profit. The company's net worth dipped by a decrease of 1.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kosvo Pharmaceuticals India?
Unlock access to Kosvo Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Linkage Technik Online Service Private LimitedPritish Agarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kosvo Pharmaceuticals India?
Unlock and access historical data on people associated with Kosvo Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kosvo Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kosvo Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.